Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Volume: 15, Issue: 11, Pages: 1478 - 1488
Published: Sep 5, 2019
Abstract
Introduction null Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies are targeted to specific proteins or are biased toward high abundant proteins. null Methods null 4001 plasma proteins were measured in two groups of participants (discovery group = 516, replication...
Paper Details
Title
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Published Date
Sep 5, 2019
Volume
15
Issue
11
Pages
1478 - 1488
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.